Literature DB >> 7021561

Management of deep infection of total hip replacement.

H W Buchholz, R A Elson, E Engelbrecht, H Lodenkämper, J Röttger, A Siegel.   

Abstract

Exchange operation is recommended as the treatment of choice for most deep infections involving a total hip replacement. This revision arthroplasty comprises, in one stage, excision of soft tissue, removal of implant and cement, replacement with an appropriate implant using Palacos R acrylic cement loaded with an appropriate antibiotic and, more recently, systemic antibiotics. During our first 10 years without systemic antibiotics we have achieved an overall 77 per cent success rate from a first attempt in 583 patients and a 90 per cent success rate after subsequent exchange procedures. Morbidity is significant but acceptable. Success is defined as control of infection, no loosening, and useful function. The factors associated with failures include, in particular, specific infections (Pseudomonas group, Streptococcus group D, Proteus group, and Escherichia coli), delay in operation and inadequate antibiotic dosage in the cement.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7021561

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  97 in total

1.  Prosthetic Joint Infection.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

2.  Treatment Options for Orthopedic Device-related Infections.

Authors:  Edna Toubes; John Segreti
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

3.  [One stage revision of infected total hip replacements with replacement of bone loss by allografts. Study of 90 cases of which 46 used bone allografts].

Authors:  B Loty; M Postel; J Evrard; P Matron; J P Courpied; M Kerboull; B Tomeno
Journal:  Int Orthop       Date:  1992       Impact factor: 3.075

4.  Salvage of the infected arthroplasty.

Authors:  A C Ross
Journal:  Ann Rheum Dis       Date:  1992-07       Impact factor: 19.103

Review 5.  [Periprosthetic knee infection. One-stage exchange].

Authors:  C Friesecke; J Wodtke
Journal:  Orthopade       Date:  2006-09       Impact factor: 1.087

6.  Experimental research on the use of an antineoplastic drug with a bone implant.

Authors:  W Y Guan; W T Yi; M Y Zhi; S S Zhen
Journal:  Int Orthop       Date:  1990       Impact factor: 3.075

7.  [The infected implant].

Authors:  J Wodtke; J F Löhr
Journal:  Orthopade       Date:  2008-03       Impact factor: 1.087

8.  Pathogenesis of foreign body infection. Evidence for a local granulocyte defect.

Authors:  W Zimmerli; P D Lew; F A Waldvogel
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

9.  Sustained release of antibiotics from injectable and thermally responsive polypeptide depots.

Authors:  Samuel B Adams; Mohammed F Shamji; Dana L Nettles; Priscilla Hwang; Lori A Setton
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2009-07       Impact factor: 3.368

10.  Does pre-operative sampling predict intra-operative cultures and antibiotic sensitivities in knee replacements revised for infection?: a study using the NJR dataset.

Authors:  Richard J Holleyman; David J Deehan; Andre Charlett; Kate Gould; Paul N Baker
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-11-26       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.